• FirefoxInstall the new Firefox »
  •  Dow Up 0.86% Nasdaq Up 0.90%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    184.62 Up 4.25(2.36%) 4:00PM EST
    |After Hours : 184.62 0.00 (0.00%) 5:05PM EST
    Add to Portfolio
    Prev Close:180.37
    Open:180.34
    Bid:184.00 x 1200
    Ask:186.30 x 100
    1y Target Est:214.41
    Beta:1.21
    Earnings Date:Apr 22 - Apr 27 (Est.)
    Day's Range:180.09 - 184.73
    52wk Range:136.37 - 203.30
    Volume:970,970
    Avg Vol (3m):1,266,780
    Market Cap:37.32B
    P/E (ttm):56.63
    EPS (ttm):3.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALXN

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 2.36%37.32B
    AMGNUp 1.21%121.14B
    BAXUp 1.17%37.96B

    Key Statistics

    Forward P/E (1 yr):25.22
    P/S (ttm):16.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :5.91
    Quarterly EPS Est (Mar-15) :1.33
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.21

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback